1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
date : 6/28/2013
1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
The discussion will investigate the issues surrounding end of life care to examine comprehensive points of view. This allows multispectral speakers to exchange their opinions in order to share the points at the issue with citizens.
Data: July 2nd (Tuesday) 19:00-21:00
Place: Tokyo 21c club (Shin-Marunouchi Build. 10F 1-5-1Marunouchi, Chiyoda-ku, Tokyo)
Organized by: Health and Global Policy Institution, NPO
Points of view: It allows multispectral speakers to exchange their opinions.
Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (Reservation only)
Language: Japanese (No interpretation)
Program:
1. Discussion Point of EOL Care (Mr. Kazuhisa Takeuchi (McKinsey and Company ))
2. Philosophy of Life/Death and Community (Speaker:Yoshinori Hiroi (Professor at Chiba University, School of Law)
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 (Syllabary order, Titles omitted)
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/ Surgeon
Exhibition date:2013-07-02
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)



